| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| « Mar | May » | |||||
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 | ||||||
April 16th, 2012 tmccoy
by: Stephanie Herschaft, Esq. Bayer has agreed to pay at least $110 million to Yasmin claimants in order to settle the first 500 lawsuits over claims that its Yasmin group of birth-control pills caused blood clots in the young women using them. According to newsinferno.com, 11,000 plaintiffs have filed suit against Bayer alleging that Yaz [...]
April 16th, 2012 tmccoy
by: Jonathan Macri, Esq. Gilenya, a relatively new drug used to treat multiple sclerosis that is put out by Novartis AG, has been linked with a potentially deadly brain infection in at least one patient taking the product. The patient had already been taking Tysabri, another MS drug, at the time she started Gilenya, and [...]
April 16th, 2012 tmccoy
by: Michael Werner, Esq. On April 12, 2012 the Medicines & Healthcare products Regulatory Agency issued yet another warning regarding higher than expected revision rates for metal-on-metal total hip replacement systems containing components made by Johnson and Johnson’s DePuy Orthopedics division and Stryker. The warning specifically highlights DePuy’s Mitch TRH acetabular cups and Mitch TRH [...]
